236 related articles for article (PubMed ID: 26763968)
1. Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA.
Hong F; Aga E; Cillo AR; Yates AL; Besson G; Fyne E; Koontz DL; Jennings C; Zheng L; Mellors JW
J Clin Microbiol; 2016 Apr; 54(4):902-11. PubMed ID: 26763968
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
Eriksson S; Graf EH; Dahl V; Strain MC; Yukl SA; Lysenko ES; Bosch RJ; Lai J; Chioma S; Emad F; Abdel-Mohsen M; Hoh R; Hecht F; Hunt P; Somsouk M; Wong J; Johnston R; Siliciano RF; Richman DD; O'Doherty U; Palmer S; Deeks SG; Siliciano JD
PLoS Pathog; 2013 Feb; 9(2):e1003174. PubMed ID: 23459007
[TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
4. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
[TBL] [Abstract][Full Text] [Related]
6. Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.
Lee EM; Chung HK; Livesay J; Suschak J; Finke L; Hudacik L; Galmin L; Bowen B; Markham P; Cristillo A; Pal R
J Virol Methods; 2010 Feb; 163(2):287-94. PubMed ID: 19878696
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy.
Leth S; Nymann R; Jørgensen S; Olesen R; Rasmussen TA; Østergaard L; Denton PW; Tolstrup M; Søgaard OS
AIDS; 2016 Mar; 30(5):713-21. PubMed ID: 26595541
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.
de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ
PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315
[TBL] [Abstract][Full Text] [Related]
9. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
10. Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays.
Hopkins M; Hau S; Tiernan C; Papadimitropoulos A; Chawla A; Beloukas A; Geretti AM
J Clin Virol; 2015 Aug; 69():56-62. PubMed ID: 26209380
[TBL] [Abstract][Full Text] [Related]
11. Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells.
van Zyl GU; Bedison MA; van Rensburg AJ; Laughton B; Cotton MF; Mellors JW
J Infect Dis; 2015 Jul; 212(1):39-43. PubMed ID: 25538273
[TBL] [Abstract][Full Text] [Related]
12. Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART.
Mortier V; Demecheleer E; Staelens D; Schauvliege M; Dauwe K; Dinakis S; Hebberecht L; Vancoillie L; Verhofstede C
J Clin Virol; 2018 Sep; 106():58-63. PubMed ID: 30077957
[TBL] [Abstract][Full Text] [Related]
13. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial.
Geretti AM; Arribas JR; Lathouwers E; Foster GM; Yakoob R; Kinloch S; Hill A; van Delft Y; Moecklinghoff C
HIV Clin Trials; 2013; 14(1):45-50. PubMed ID: 23372114
[TBL] [Abstract][Full Text] [Related]
15. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
[TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.
Zaccarelli M; Santoro MM; Armenia D; Borghi V; Gennari W; Gori C; Forbici F; Bertoli A; Fabeni L; Giannetti A; Cicalini S; Bellagamba R; Andreoni M; Mastroianni CM; Mussini C; Ceccherini-Silberstein F; Perno CF; Antinori A
J Clin Virol; 2016 Sep; 82():94-100. PubMed ID: 27472519
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
[TBL] [Abstract][Full Text] [Related]
18. HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
Burgard M; Izopet J; Dumon B; Tamalet C; Descamps D; Ruffault A; Vabret A; Bargues G; Mouroux M; Pellegrin I; Ivanoff S; Guisthau O; Calvez V; Seigneurin JM; Rouzioux C
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1939-47. PubMed ID: 11153076
[TBL] [Abstract][Full Text] [Related]
19. Whole blood as an alternative to peripheral blood mononuclear cell for detection of total HIV-1 DNA.
Lin L; Yue YS; Wang ND; Wei LY; Han Y; Song XJ; Qiu ZF; Cao W; Li TS
BMC Infect Dis; 2020 Dec; 20(1):941. PubMed ID: 33302895
[TBL] [Abstract][Full Text] [Related]
20. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
Pasternak AO; Jurriaans S; Bakker M; Berkhout B; Lukashov VV
AIDS; 2010 Jul; 24(11):1641-9. PubMed ID: 20543660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
